Hangover Joe’s Holding Corp (OTCMKTS:HJOE) informed that it ended first production process of hangover recovery shot formulation aimed for Cure Korea. With the completion of the run, the company has commenced with the shipment of recovery shots to South Korea. It can be a major breakthrough for the company as Cure Korea is a leading distributor firm in South Korea and had an expert team that understands the market thoroughly.
The achievement
The recent news marks a significant accomplishment for Hangover. The team had been working on hangover recovery shot for South Korea market for over a year. It was required to pass the approval process set by MFDS. It can be stated as a Korean form of the FDA. With it, the people of Korea can now buy hangover recovery shots to say bye to hangover.
It is important to note that that South Korea is included in the list of leading countries famous for higher alcohol consumption. The distributor firm, Cure Korea has started the process and already supplied the recovery shots to leading grocery stores, big box stores, and convenience store chains in the nation.
The scope
In South Korea, beverages are sometimes treated as a pressure valve, enabling consumers to get rid of frustrations. Also, it serves as a lubricant for the business promoting growth. Hangover recovery shots are going to be of great significance for both people and businesses.
South Koreans will be able to get hangover recovery medication every morning. The stringent social guidelines of South Korea appear to be absorbed in alcohol. As a matter of fact, drinking is reckoned as n integral part of people’s lives in South Korea.
In last trading session, the stock price of Hangover Joe’s declined more than 9% to close the trading session at $0.00380. The decline came at a share volume of 24.11 million compared to average share volume of 91.08 million.
